54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 31
00:43 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Yanan Zhu ★★☆☆☆ #2604 | Overweight | $100.00→ $95.00-5.0% |
|
Jul 31
00:43 UTC
|
IGM
IGM Financial
|
◎ Target | firm only | Buy | C$92.00→ C$94.00+2.2% |
|
Jul 31
00:43 UTC
|
IGM
IGM Financial
|
◎ Target | firm only | Sec→ r Perform | C$84.00→ C$87.00+3.6% |
|
Jul 31
00:43 UTC
|
IFC
Intact Financial
|
◎ Target | firm only | Sec→ r Perform | C$299.00→ C$308.00+3.0% |
|
Jul 31
00:43 UTC
|
IFC
Intact Financial
|
◎ Target | firm only | Sec→ r Outperform | C$330.00→ C$325.00-1.5% |
|
Jul 31
00:43 UTC
|
IFC
Intact Financial
|
◎ Target | firm only | C$314.00→ C$311.00-1.0% | |
|
Jul 31
00:43 UTC
|
IEX
IDEX
|
◎ Target | Nathan Jones ★★★☆☆ #1682 | Buy | $257.00→ $268.00+4.3% |
|
Jul 31
00:43 UTC
|
IEX
IDEX
|
◎ Target | Vladimir Bystricky not yet tracked | Buy | $252.00→ $269.00+6.7% |
|
Jul 31
00:43 UTC
|
IEX
IDEX
|
◎ Target | Deane Dray ★★★☆☆ #1828 | Outperform | $261.00→ $280.00+7.3% |
|
Jul 31
00:43 UTC
|
IEX
IDEX
|
◎ Target | Joe Giordano not yet tracked | Buy | $260.00→ $275.00+5.8% |
|
Jul 31
00:43 UTC
|
IBST
Ibstock
|
◎ Target | firm only | Outperform | GBX 160→ GBX 130-18.8% |
|
Jul 31
00:43 UTC
|
IART
Integra LifeSciences
|
◎ Target | Larry Biegelsen ★★★★☆ #858 | Equal Weight | $15.00→ $18.00+20.0% |
|
Jul 31
00:43 UTC
|
HUM
Humana
|
◎ Target | A.J. Rice ★★★★☆ #448 | Neutral | $320.00→ $405.00+26.6% |
|
Jul 31
00:43 UTC
|
HUM
Humana
|
◎ Target | Jason Cassorla ★★★★☆ #441 | Buy | $269.00→ $471.00+75.1% |
|
Jul 31
00:43 UTC
|
HTWS
Helios Towers
|
◎ Target | firm only | Buy | GBX 275→ GBX 295+7.3% |
|
Jul 31
00:43 UTC
|
HSW
Hostelworld Group
|
◎ Target | firm only | Buy | GBX 205→ GBX 185-9.8% |
|
Jul 31
00:43 UTC
|
HOOD
Robinhood Markets
|
◎ Target | James Yaro ★★★☆☆ #1396 | Buy | $137.00→ $118.00-13.9% |
|
Jul 31
00:43 UTC
|
HOOD
Robinhood Markets
|
◎ Target | Benjamin Budish ★★★★☆ #729 | Overweight | $122.00→ $105.00-13.9% |
|
Jul 31
00:43 UTC
|
HOOD
Robinhood Markets
|
◎ Target | John Todaro ★☆☆☆☆ #3213 | Buy | $123.00→ $120.00-2.4% |
|
Jul 31
00:43 UTC
|
HLT
Hilton Worldwide
|
◎ Target | Trey Bowers ★★★☆☆ #1439 | Overweight | $379.00→ $382.00+0.8% |
|
Jul 31
00:43 UTC
|
HLI
Houlihan Lokey
|
◎ Target | Alex Bond ★★★☆☆ #1647 | Outperform | $160.00→ $153.00-4.4% |
|
Jul 31
00:43 UTC
|
HLI
Houlihan Lokey
|
◎ Target | Ryan Kenny ★★★☆☆ #1405 | Overweight | $187.00→ $177.00-5.3% |
|
Jul 31
00:43 UTC
|
HLI
Houlihan Lokey
|
◎ Target | Richard Ramsden ★★★☆☆ #993 | Buy | $171.00→ $148.00-13.5% |
|
Jul 31
00:43 UTC
|
HLI
Houlihan Lokey
|
◎ Target | Michael Brown ★★★★☆ #466 | Neutral | $161.00→ $147.00-8.7% |
|
Jul 31
00:43 UTC
|
HBM
Hudbay Minerals
|
◎ Target | firm only | Sec→ r Outperform | C$44.00→ C$43.00-2.3% |
|
Jul 31
00:43 UTC
|
HBM
Hudbay Minerals
|
◎ Target | firm only | Outperform | C$35.50→ C$35.00-1.4% |
|
Jul 31
00:43 UTC
|
HBM
Hudbay Minerals
|
◎ Target | firm only | Buy | C$40.00→ C$39.50-1.2% |
|
Jul 31
00:43 UTC
|
HBM
Hudbay Minerals
|
◎ Target | firm only | Outperform | C$46.00→ C$44.00-4.3% |
|
Jul 31
00:43 UTC
|
GWO
Great-West Lifeco
|
◎ Target | firm only | Sec→ r Perform | C$77.00→ C$91.00+18.2% |
|
Jul 31
00:43 UTC
|
GWO
Great-West Lifeco
|
◎ Target | firm only | Market Perform | C$90.00→ C$92.00+2.2% |
|
Jul 31
00:43 UTC
|
GWO
Great-West Lifeco
|
◎ Target | firm only | C$93.00→ C$95.00+2.2% | |
|
Jul 31
00:43 UTC
|
GWO
Great-West Lifeco
|
◎ Target | firm only | Sec→ r Outperform | C$95.00→ C$100.00+5.3% |
|
Jul 31
00:43 UTC
|
GWO
Great-West Lifeco
|
◎ Target | firm only | C$95.00→ C$97.00+2.1% | |
|
Jul 31
00:43 UTC
|
GRMN
Garmin
|
◎ Target | Tim Long ★★★☆☆ #1976 | Equal Weight | $238.00→ $297.00+24.8% |
|
Jul 31
00:43 UTC
|
GRMN
Garmin
|
◎ Target | Erik Woodring ★★★☆☆ #1523 | Equal Weight | $249.00→ $289.00+16.1% |
|
Jul 31
00:43 UTC
|
GRG
Greggs
|
◎ Target | firm only | Outperform | GBX 2,050→ GBX 2,210+7.8% |
|
Jul 31
00:43 UTC
|
GRG
Greggs
|
◎ Target | firm only | Buy | GBX 2,090→ GBX 2,200+5.3% |
|
Jul 31
00:43 UTC
|
GNRC
Generac
|
◎ Target | Christine Cho ★★★☆☆ #1480 | Equal Weight | $285.00→ $278.00-2.5% |
|
Jul 31
00:43 UTC
|
GNRC
Generac
|
◎ Target | Stephen Gengaro ★★☆☆☆ #2555 | Buy | $275.00→ $285.00+3.6% |
|
Jul 31
00:43 UTC
|
GNRC
Generac
|
◎ Target | George Gianarikas ★☆☆☆☆ #3222 | Buy | $325.00→ $275.00-15.4% |
|
Jul 31
00:43 UTC
|
GNRC
Generac
|
◎ Target | Manish A. Somaiya not yet tracked | Overweight | $325.00→ $333.00+2.5% |
|
Jul 31
00:43 UTC
|
GLEN
Glencore
|
◎ Target | firm only | Buy | GBX 780→ GBX 750-3.8% |
|
Jul 31
00:43 UTC
|
GLEN
Glencore
|
◎ Target | firm only | Neutral | GBX 520→ GBX 510-1.9% |
|
Jul 31
00:43 UTC
|
GKOS
Glaukos
|
◎ Target | Yi Chen ★★☆☆☆ #2405 | Buy | $168.00→ $195.00+16.1% |
|
Jul 31
00:43 UTC
|
GKOS
Glaukos
|
◎ Target | Tom Stephan not yet tracked | Buy | $175.00→ $190.00+8.6% |
|
Jul 31
00:43 UTC
|
GKOS
Glaukos
|
◎ Target | Joanne Wuensch ★★★★★ #205 | Buy | $175.00→ $188.00+7.4% |
|
Jul 31
00:43 UTC
|
GKOS
Glaukos
|
◎ Target | Richard Newitter ★★★★☆ #460 | Buy | $180.00→ $215.00+19.4% |
|
Jul 31
00:43 UTC
|
GKOS
Glaukos
|
◎ Target | Larry Biegelsen ★★★★☆ #858 | Overweight | $138.00→ $178.00+29.0% |
|
Jul 31
00:43 UTC
|
GKOS
Glaukos
|
◎ Target | David Saxon ★★★★★ #312 | Buy | $150.00→ $201.00+34.0% |
|
Jul 31
00:43 UTC
|
GKOS
Glaukos
|
◎ Target | Ryan Zimmerman ★★★☆☆ #1554 | Buy | $164.00→ $193.00+17.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.